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PREBAIT SEROLOGY
Paul C. Ramey,1 Bradley F. Blackwell,2 Robert J. Gates,1,4 and Richard D. Slemons3
1

Ohio State University, School of Environment and Natural Resources, 2021 Coffey Road, Columbus, OH 43210, USA
United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National
Wildlife Research Center, Ohio Field Station, 6100 Columbus Avenue, Sandusky, OH 44870, USA
3
Ohio State University, Veterinary Preventive Medicine, 1920 Coffey Road, Columbus, OH 43210, USA
4
Corresponding author (email: gates.77@osu.edu)
2

Ohio’s oral rabies vaccination (ORV) program was established to prevent the
westward spread of the raccoon (Procyon lotor) rabies virus (Lyssavirus, Rhabdoviridae) in Ohio,
USA. The program, which targets raccoons, distributes vaccine-bait units (VBU) at a target
density of 75 units/km2. Few studies have examined the relationship of VBU density and target
population density to the prevalence of rabies virus-neutralizing antibodies (RVNA). We
conducted experimental VBU distributions in August 2003 and August 2004, 150 km west of the
ORV zone where there was no history of raccoon rabies. We measured change in RVNA titers in
blood collected from live-trapped raccoons before and after VBU distributions. A closed
population mark–recapture estimate of the size of the target population was 91 raccoons/km2,
compared to the realized VBU distribution density of 70 units/km2. Surprisingly, 41% of 37 serum
samples were RVNA-positive ($0.05 IU/ml) before VBU distribution in 2003, but all titers were
,0.25 IU/ml. Although viable VBUs were distributed in August 2003, only 21% of 315 samples
were RVNA-positive before VBU distribution in 2004, but 9% had titers $0.25 IU/ml.
Tetracycline (biomarker in bait) prevalence in teeth indicated that 57% of raccoons ingested
VBUs after distribution in 2003, and 54% ingested VBUs after distribution in 2004. However, only
8% and 11% of sera were positive for RVNA ($0.05 IU/ml) after VBU distribution in 2003 and
2004, respectively. Only 4–5% of sera collected after bait distribution had titers $0.25 IU/ml each
year. The standard distribution density of 75 VBUs/km2 was insufficient to produce a populationwide immunoprotective response against rabies infection in our high-density target population.
Presence of RVNA in a presumed naı̈ve population before baiting demonstrates that estimating
prevalence of RVNA after oral rabies vaccination can be problematic without knowledge of
background titers and seasonal changes in prevalence of RVNA before and after baiting.
Key words: Oral rabies vaccination, population density, Procyon lotor, rabies virus, virusneutralizing antibodies, raccoon, vaccination, V-RG.
ABSTRACT:

USA, since 1997. The Ohio Department of
Health (ODH) began distributing oral
rabies vaccines (ORV) after an epizootic
produced 62 cases of raccoon rabies in
eastern Ohio during 1997 (ODH, 2002).
There were no reported raccoon-variant
rabies cases in eastern Ohio by 2000 and
only one to two cases per year thereafter
(ODH, 2004); however, in 2004, 45 confirmed case of raccoon rabies were observed in northeastern Ohio (Fig. 1;
ODH, 2006a). The 2004 outbreak was
contained with intensive aerial and ground
baiting with ORV. The Ohio ORV zone is
part of a larger ORV program that follows
natural land features along the Appalachian Ridge, creating a barrier westward
of raccoon-variant rabies (Fig. 2).

INTRODUCTION

Large-scale distribution of oral rabies
vaccine-bait units (VBUs) was prompted
by the mid-Atlantic epizootic of raccoon
(Procyon lotor) variant rabies in the
eastern United States in the 1980s (Rupprecht et al., 1995). A vaccinia-rabies
glycoprotein (V-RG) recombinant virus
vaccine that produces a detectable rabies
virus-neutralizing antibody (RVNA) titer
($0.05 IU/ml) in laboratory animals
(Rupprecht et al., 1988; Hanlon et al.,
2002) has subsequently been utilized in
control programs (Slate et al., 2005).
Aerial distribution of VBUs has been
ongoing throughout the eastern United
States since the early 1990s, and in Ohio,
553
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FIGURE 1. Annual numbers of reported raccoon
rabies cases in Ohio during 1996–2006 (as of 5
October 2006; ODH 2006b).

The standard operational baiting protocol distributes 75 VBU/km2 over large
areas where raccoon population densities
are highly variable. Baits are distributed at
higher densities in suburban interface
areas where high raccoon densities are
known or expected to occur. The level of
herd immunity achieved by baiting at
varying densities of VBU and target
population densities is not well understood. However, RVNA prevalence in
raccoons increased when VBU density
was increased from 75 to 300 baits/km2
(ODH, 2001). Prevalence of RVNA is also
measured by US Department of Agriculture–Wildlife Services (WS) after VBUs
are distributed during the operational
baiting program. No study or evaluation
to date has measured host density or
prevalence of RVNA in a naı̈ve target
population before VBUs were distributed.
Prevalence of RVNA due to VBU distribution could be overestimated if RVNA
was present in the population before VBU
distribution. Further, without estimates of
raccoon population density it is unclear
whether the standard target VBU distribution density (75 units/km2; ODH, 2001;
WS, 2004) is sufficient to vaccinate all
target populations. Knowledge of target
population densities and prevaccination
serology are needed to plan and evaluate
the effectiveness of ORV distribution
programs.

FIGURE 2. Location of Plum Brook Station relative to the 2004 eastern Ohio and Appalachian Ridge
Oral Rabies Vaccination (ORV) zones.

This study measured change in RVNA
prevalence among raccoons after distributing VBUs (target density 75 units/km2)
in an area with no known history of
raccoon rabies and where raccoon population density was estimated at the time of
baiting. Our objectives were to 1) estimate
raccoon population density within the
baited area and 2) determine RVNA
prevalence and presence of a VBU biomarker (tetracycline) in teeth in raccoons
before and after distribution of VBUs
following the Ohio operational protocol.
We expected that RVNA would not be
present in the population before we
distributed baits and that RVNA prevalence would increase in the population
after distribution of VBUs at 75 baits/km2.
We also predicted that post-bait prevalence and RVNA titers would increase
between an initial baiting in 2003 and a
second baiting in 2004.
MATERIALS AND METHODS
Study area

The study was conducted on the National
Aeronautics and Space Administration (NASA)
Plum Brook Station (hereafter, Plum Brook).
Plum Brook includes 22 km2 and is located
within the Lake Erie coastal plane in northern
Ohio, ,4 km south of Sandusky in Erie
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County (41u279N, 82u429W) and 150 km west
of the Appalachian Ridge oral rabies vaccination zone (Fig. 2). The site encompasses active
research facilities, abandoned warehouses,
barns, trailers, and outbuildings. Vegetation
communities present on Plum Brook consist of
40% herbaceous field, 30% shrubland (Cornus
spp.), and 30% oak-dominated (Quercus spp.
and Populus spp.) hardwood forest (Linhart et
al., 2002; NASA, 2002). Human access to Plum
Brook is controlled through a 2-m-high chainlink fence topped with barbed wire that
encloses the 22-km perimeter and a guardhouse centrally located on the northern
boundary. Restricted-access roads traverse
the interior of Plum Brook and a paved patrol
road parallels the entire perimeter fence.
Creeks and ponds provide permanent sources
of water throughout Plum Brook. Areas south
and east of Plum Brook are mostly cropland,
including corn (Zea mays), soybean (Glycine
max), and wheat (Triticum aestivum). The
northern boundary abuts suburban residential
property, whereas the western boundary
adjoins a mixture of residential and agricultural areas. There were no physical boundaries
to prevent movement of raccoons between
Plum Brook and the surrounding area.
Oral rabies vaccine

The Raboral V-RGH (Merial, Duluth, Georgia, USA) vaccine used in this study is licensed
for oral vaccination of raccoons (Hanlon et al.,
2002), and is currently used in state and
federal rabies-control programs (Slate et al.,
2005). The bait is a hollow cube of fish-meal
polymer and wax that seals a plastic sachet that
contains the V-RG vaccine. Tetracycline is
mixed with the fish-meal polymer to serve as a
biomarker of bait ingestion (Linhart and
Kennelly, 1967; Nunan et al., 1994). Orally
administered tetracycline can be detected in
calcific tissues of mammals after 2 days postconsumption (Hanlon et al., 1989). Raccoons
are exposed to the vaccine only if the sachet is
punctured and a sufficient vaccine dose is
ingested to elicit serologic response. Because
the vaccinia virus vector also replicates in the
infected host, detection of vaccinia virus
antibodies (VVA) may be used as an indicator
of serologic response to the vaccine.
Trapping

Raccoons were live-trapped and ear-tagged
from 6 May 2003 to 16 October 2003 and from
30 March 2004 to 21 October 2004 within
eight 1-km2 grids that were representative of
habitats on Plum Brook (Fig. 3). The eight
grids were grouped into four pairs such that
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FIGURE 3. Minimum convex polygon containing
95% of locations of radio-marked raccoons, boundaries of Plum Brook Station, 1-km2 trapping grids,
and flight lines used to distribution oral rabies
vaccine bait units during 2003 and 2004 in Erie
County, Ohio, USA.

each pair was separated by $1 km at the
closest point; each grid included 30 possible
trapping points, spaced 250 m apart. Trapping
was done throughout the season on one
randomly selected half of each grid (north,
south, east, or west). The 15 trapping points in
selected grid halves were divided into three
subsets. Two of three subsets were trapped in
each grid half during each week. We rotated
trap placement in a fixed order between the
three subsets of possible locations every 4 wk
so that every point within the grid half was
trapped at least twice.
Each grid pair (i.e., 20 traps/night) was
trapped for four nights; and grid pairs were
rotated each week so that all eight grids were
trapped once every 4 wk. One rotation
through all eight grids was considered a single
trapping period. Six rotations (four prebait and
two post-bait) were completed during 2003
and seven (5 prebait and two post-bait) during
2004.
Trapping effort varied from 10 traps/night
during the first week of trapping to 40 traps/
night during the last week (x̄520 traps/night)
in 2003. Trapping effort in 2004 was constant
throughout the season (20 traps/night). All
traps that captured nontarget species or where
bait was missing were counted as 0.5 trapnights (Beauvais and Buskirk, 1999). Youngof-the-year raccoons were too small to tag and
were released after capture.
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Two previous placebo VBU studies were
conducted on Plum Brook (Linhart et al.,
2002; Blackwell et al., 2004). We sampled a
reference raccoon population in 2004 at Old
Woman Creek (OWC) National Estuarine
Research Reserve 15 km east of Plum Brook
(41u229N, 82u319W) after unexpectedly detecting RVNA before VBU distribution in
2003. Five traps were placed opportunistically
at OWC one night per week during the 2004
trapping season.
Single-door, live-catch cage traps (Tomahawk 108.5, 107330330 cm; Tomahawk,
Wisconsin, USA) baited with marshmallows
and a 4:3:1 vanilla extract:honey:anise extract
mixture were used for capture. Raccoons
were anesthetized with a 5:1 ketamine:xylazine
solution of 100 mg/ml each administered at
a dosage of 12 mg/kg as described (ODH,
2002). Sedated animals were removed from
traps, checked for presence of ear tags, and
assessed for overall condition; body weight,
sex, and age (adult, subadult, juvenile) were
recorded. Age was estimated by tooth development and wear, the presence/absence of the
penile frenulum for males, and mammary
gland development for females (Lotze and
Anderson, 1979). Animals were marked with
one tag (Hasco 1005-3; Dayton, Kentucky,
USA) in each ear.
Blood collection and analysis

Blood samples (approximately 10 ml) were
collected from the jugular vein with a 21gauge 4-cm needle attached to a vacuum tube
after shaving and cleansing the ventral portion
of the neck with isopropyl alcohol. Blood
samples were stored (,6 hr) in a cooler until
centrifuging (Clay Adams Dynac Centrifuge
420101; Franklin Lakes, New Jersey, USA) for
20 min at 800 3 G. Serum was divided among
three cryovials, each containing $0.5 ml and
stored at 220 C. Two serum samples were
kept in reserve and one was shipped to the
Centers for Disease Control and Prevention
(CDC) to be analyzed for RVNA titer, via the
rapid fluorescent focus inhibition test (Reagan
et al., 1983). Vaccinia virus antibody titers
were determined (2003 only) by the CDC
using the enzyme-linked immunosorbent assay
(Marennikova et al., 1981).
Tooth extraction and tetracycline analysis

The first premolar was extracted for aging
and biomarker analysis while the animal was
sedated. The premolar is a single-rooted tooth
(absent in some individuals) that is more easily
extracted than a canine; premolar extraction is
reported not to affect recapture rates of

raccoons (Beasley and Rhodes, 2007). The
extracted premolar was placed in an envelope
labeled with the animal’s identification number and collection date; teeth were not
extracted from individuals without first premolars.
Teeth were collected before and after ORV
distribution to establish a baseline to distinguish tetracycline deposited during our study
from past placebo ORV experiments on Plum
Brook (Linhart et al., 2002; Blackwell et al.,
2004). Age, presence of tetracycline, and year
of tetracycline deposition were determined by
cross-sectioning the teeth and examining tooth
annuli (Matson’s Laboratory, LLC, Milltown,
Montana, USA).
Radiotelemetry

Some captured adult (.1 yr) raccoons were
fitted with 130-g radio collars equipped with
mortality switches (Advanced Telemetry Systems, Isanti, Minnesota, USA). Eight males
and nine females were radio-collared from 10
September 2003 to 24 September 2003; 22
males and 22 females were radio-collared from
22 June 2004 to 24 September 2004; these
raccoons were monitored from from 23
September 2003 to 31 October 2003 and from
22 June 2004 to 23 November 2004. All
animals were checked once per week for
changes in signal pulse that indicated mortality
(after 8 hr of inactivity). Raccoons were
located by triangulation using handheld Yagi
antennas (Ellis, 1964) three to five times per
night between sunset and sunrise, and over
one to three nights every 1–2 wk. A set of
three or more bearings was obtained on each
animal, typically within 10- to 15-min periods.
Triangulation bearings were plotted on a
computer in the field (LOCATE II; Nams
2000) and inconsistent bearings were discarded. We used the animal movement extension
operating with Spatial Analyst in ARCVIEW
3.2 (Hooge and Eichenlaub, 2000) to obtain
the minimum convex polygon (MCP) area that
encompassed all locations of radio-collared
raccoons. This MCP, the spatial ‘‘footprint’’ of
our study population, was used to calculate
density from abundance estimates based on
mark–recapture data. The Kaplan–Meier
method was used to estimate weekly survival
rates of radio-marked raccoons (Heisey and
Fuller, 1985). All animal handling procedures
followed protocol 2003A0119, approved by the
Ohio State University Institutional Laboratory
Animal Care and Use Committee and reviewed by the Institutional Animal Care and
Use Committee convened by the WS National
Wildlife Research Center.
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Density estimation

The raccoon population was estimated by
mark–recapture. Individual raccoons typically
have unique capture probabilities (Gehrt and
Fritzell, 1998) that change over time due to
trap experience and recruitment of trap-naı̈ve
juveniles into the population (Moore and
Kennedy, 1985). Population estimates from
closed-population models that relax assumptions about effects of capture heterogeneity,
trap response, and time were evaluated
(Pollock et al., 1990). Program CAPTURE
(Pollock et al., 1990) was used to estimate
adult population size (695% confidence
interval).
Only adult raccoons were used in population estimates to meet the population closure
assumption and the adult raccoon density
estimate was doubled to account for juveniles
present in the population at the time of
baiting. We assumed an average fecundity of
two kits per female per year (Ritke, 1990) and
a 1:1 sex ratio, which is typical for wild
raccoons (Broadfoot et al., 2001). Departure
from an even sex ratio in the trapped sample
was evaluated with chi-square tests (a50.05).
We simulated the method used by WS to
estimate relative densities of raccoons in
baited areas (WS, 2004). The WS relativedensity estimator is based on the minimumnumber-known-alive (MNKA) method, the
simplest mark–recapture estimator, but with
the most restrictive assumptions (population
closure, constant homogeneous capture probabilities; Pollock et al., 1990). The MNKA
method assumes that all animals present are
captured with a sufficient level of trapping
effort. The WS protocol uses a rectangular or
circular 3-km2 area, selected to represent
surrounding habitat (WS, unpubl.). Fifty livetraps, baited with anise/vanilla and marshmallows, are placed opportunistically without
clumping throughout the area to maximize
captures. If 50 live traps capture #2 unique
raccoons over four consecutive nights, then
trapping ceases on the fifth day and MNKA
estimates of population density are based on
250 trap-nights. Trapping continues for five
more nights and MNKA estimates are based
on 500 trap-nights if ,75 unique raccoons are
captured over the 10-night period. If $75
individual raccoons are captured after 10
nights and the proportion of unique individuals captured is $0.05, then trapping continues for another five nights and MNKA
estimates are based on 750 trap-nights.
The WS criteria was met for the third level
of trapping effort, so the number of unique
individuals captured during $700 trap-nights
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each year was determined. We accumulated
700 (2003) and 720 (2004) trap-nights from
three of the grid pairs over three fourconsecutive-night trapping periods separated
by 4 wk for each grid (10 traps/grid3four
nights3three periods3six grids5720 trapnights). Thus, our simulation of the WS
protocol began when trapping commenced in
May and ended in August. We averaged
MNKA estimates over four simulations in
which one unique grid pair was withheld.
Catch-per-unit effort (CPUE) is another
population estimator that accounts for untrapped individuals remaining after completing the WS relative density protocol. Consequently, capture data also were analyzed using
a CPUE removal model. In contrast to
MNKA, CPUE does not require that all
animals are captured, but does assume population closure and constant and homogeneous
capture probabilities. The CPUE model also
assumes that every individual in the population is marked when no new animals are
captured. Population estimates and 95%
prediction intervals were obtained by regressing the number of new (untagged) individuals
captured/trap-night on total cumulative captures of novel individuals (White et al., 1982).
The population estimate is the x-intercept
(y50) of the least-squares line.
Population density was estimated by dividing population estimates obtained from CPUE
and Program CAPTURE by area of the MCP
that encompassed all radio-locations of radiomarked raccoons during 2003 and 2004.
Population density from MNKA was estimated
in a similar manner except that MCP areas
were calculated separately for each simulation
of the WS protocol. Specifically, we used MCP
areas derived only from locations of radiomarked raccoons that were initially captured
on the same trapping grids used in each of the
four simulations. Capture records were pooled
across trapping grids to obtain CPUE estimates in 2003 and 2004.
Vaccine bait unit distribution and viability test

Vaccine bait units were distributed on 26
August 2003 and 19 August 2004 following the
operational bait distribution protocol used in
Ohio (WS, 2004; ODH, 2006a, b); however,
VBUs were distributed by helicopter (Bell Jet
RangerH; Ft Worth, Texas, USA) rather than
fixed-wing aircraft. Baits were not distributed
over water or buildings and unlike the WS
(2004) protocol, additional VBUs were not
hand-distributed around ponds or buildings.
We distributed VBUs over 14 southeast–
northwest oriented flight lines (30–227 baits/
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line), with an estimated 27-m spacing of VBUs
along the line (Fig. 3). Flight lines were
spaced 0.5 km apart and the helicopter
traveled at a speed of 80 km/hr, and altitude
of 150 m above ground. Trapping was suspended for 1 wk after bait distribution to allow
time for animals to contact VBUs.
Vaccine viability was tested with a subsample of VBUs placed in two cage traps (10
VBUs/trap) immediately after bait distribution
in 2003. Both traps were exposed to ambient
conditions but one was exposed to direct
sunlight, whereas the other was shaded. A
third group of 10 VBUs was refrigerated at 3 C
as a control. All VBUs were collected at the
end of trapping (7 wk) and sent to the CDC
for viral vaccine titer measurement using cell
culture (Rupprecht et al., 1988).

TABLE 1. Adult population (N) with 95% confidence interval (CI) and density estimates from
minimum-number-known-alive (MNKA), catch-perunit effort (CPUE) and closed-population markrecapture model (Mth) for raccoons on Plum Brook
Station, Erie County, Ohio, USA, during May 2003
to October 2003 and March 2004 to October 2004.
Method

2003
2004

Radiotelemetry

None of 17 radio-collared raccoons died
or dispersed from Plum Brook during
2003. We detected 12 deaths among 52
radio-collared raccoons in 2004. The
Kaplan–Meier survival rate estimate was
75% when trapping ceased in 2004.
Raccoons moved outside of Plum Brook
to forage at night but nearly always returned to Plum Brook before dawn. Only
one of 52 (2%) raccoons was known to disperse beyond Plum Brook in 2004. However, we lost contact with eight (15%) raccoons before trapping ceased in 2004. The
MCP (32.8 km2) encompassing all locations
of radio-collared raccoons obtained during
2003 and 2004 extended beyond the
boundaries of Plum Brook (Fig. 3). The
MCP areas used with MNKA estimates of
population size averaged 30.3 km2 (range
26.2–32.3 km2).

No./ km2

134
192

NA
NA

4.4
6.4

438
527

182a
208a

13.4
16.1

587
248

53.4
37.5

CPUE
2003
2004
Mth
2003
2004

RESULTS

95%CI

MNKA

Statistical analyses

Chi-square tests of independence (Sokal and
Rohlf, 1995) were used to compare RVNA and
VVA prevalence (titers $0.05 IU/ml) in individual raccoons (a50.05). Chi-square was also used
to test independence of RVNA and tetracycline
prevalence. We calculated odds ratios (Sokal and
Rohlf, 1995) to determine the likelihood that a
VVA-positive raccoon was also RVNA-positive in
2003. Odds ratios also expressed the likelihood
that a tetracycline-positive raccoon was also
RVNA-positive in 2003 and 2004.

N

a

1,753
1,231

95% Confidence interval at x intercept (Sokal and Rohlf,
1995).

Target population and baiting densities

We accumulated 1,784 and 1,745 effective trap nights during 2003 and 2004,
respectively. Trap success rate was 22%
during 2003, and recapture rate (recaptured individuals/total captures) was 12%,
compared to 31% and 30%, respectively,
during 2004. Sex ratios (1.2 male:1 female
each year) in our trapped sample did not
differ from unity each year (x2#2.23,
df51, P$0.14). Age ratios (juvenile:adult)
of raccoons captured after August were
0.79:1 in 2003 and 2004. Adult females
captured with dependent young were
most frequently accompanied by two
juveniles at trap sites, supporting the 1:1
age ratio we used to account for juveniles
in our estimates of total population size.
The closed-population capture model
(Mth) produced adult population estimates
that were 8.2 and 2.1 times higher than
the MNKA and CPUE estimates, respectively, during 2003 and 2004 (Table 1).
The CPUE estimate of adult population
size was nearly two times higher than
MNKA, but only 32% of the Mth estimate.
After doubling adult Mth population estimates (to account for juveniles) and then
dividing by the effective trapping area
(32.8 km2), we estimated that raccoon
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TABLE 2. Prevalence of tetracycline by year of deposition in live-trapped raccoons before and after
distribution of oral rabies vaccine-bait units (VBUs) on Plum Brook Station, Erie County, Ohio, USA, May
2003 to October 2003 and March 2004 to October 2004.
2003 Pre-VBU

Year of deposition
2002a
2003
2004
No deposition
Total
a

2003 Post-VBU

2004 Pre-VBU

2004 Post-VBU

n

%

n

%

n

%

n

%

0
0
0
19
19

0
0
0
100
100

1
11
0
53
65

2
17
0
81
100

14
93
11
43
161

9
58
7
27
100

1
20
21
36
78

1
26
27
46
100

Likely resulting from placebo ORV bait study (Blackwell et al., 2004).

population densities at the time of baiting
were 107/km2 in 2003 and 75/km2 in 2004.
Unbaited areas (buildings, water bodies,
etc.) comprised only 6% of Plum Brook so
the realized VBU density was 70 baits/km2
(1,544 VBUs distributed each year).
Prevalence of tetracycline, VVA, and RVNA

All teeth collected during the pre-VBU
distribution (May–August) period in 2003
were tetracycline-negative (Table 2). However, tetracycline was detected in the 2002
annulus of 16 of 172 (9%) tetracyclinepositive tooth sections collected after baits
were distributed in 2003. Biomarker was
detected in the 2003 annulus of 17% of
teeth collected after VBU distribution in
2003. Tetracycline was detected in the
2003 or 2004 annuli in 26–27% of tooth
sections collected after VBU distribution in
2003. Interestingly, biomarker was detected in 73% of teeth collected during April–
August 2004, prior to the second baiting.
Most (79%) of tetracycline-positive teeth
collected before baiting in 2004 were
attributed to deposition in the 2003 annulus, but biomarker also was detected in the
2002 and 2004 annuli (9–12% of positive
tooth sections).
Nearly half of serum samples obtained
before VBU distribution in 2003 had low
positive RVNA titers (0.05#titer,0.25
IU/ml before VBU distribution (Table 3).
Only 8% of serum samples were RVNApositive after VBU distribution in 2003,
but 50% of positive samples had titers

$0.25 IU/ml (Table 3 and Fig. 4). Tetracycline-positive individuals were 2.58
times more likely to be RVNA-positive
than tetracycline-negative raccoons after
VBU distribution in 2003 (x257.79, df51,
P,0.01; Table 4).
Vaccinia virus antibodies (measured
only in 2003) showed a similar pattern to
that of RVNA titers, with 41% prevalence
before VBU distribution falling to 20%
after VBU distribution in 2003. Prevalence
of RVNA did not differ between VVApositive and VVA-negative serum samples
(odds ratio 51.13) before VBU distribution (x250.43, df51, P50.51), but VVApositive raccoons were 2.6 times more
likely to be RVNA-positive than VVAnegative raccoons after baits were distributed in 2003 (x2510.15, df51, P,0.01;
Table 5).
RVNA was present ($0.05 IU/ml) in
21% of sera collected before VBU distribution (April–August) in 2004; 9% of titers
were $0.25 IU/ml (Table 3) compared to
0% in 2003. As in 2003, the proportion of
RVNA-positive animals declined after
VBU distribution (September–October)
in 2004. Only 18% of samples were
RVNA-positive ($0.05 IU/ml) and 44%
of positives had titers $0.25 IU/ml (Table 3 and Fig. 4). Tetracycline-positive
individuals were 1.7 times more likely to
be RVNA-positive than tetracycline-negative raccoons after VBU distribution in
2004 (x253.03, df51, P50.08; Table 4).
Five of 36 (14%) serum samples col-
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TABLE 3. Prevalence of rabies virus-neutralizing antibody (RVNA) by titer level (IU/ml) in live-trapped
raccoons before and after distribution of oral rabies vaccine-bait units on Plum Brook Station, Erie County,
Ohio, USA, May 2003 to October 2003 and March 2004 to October 2004.
Prevaccine
n

Postvaccine

Total

n

%

n

%

0
0
41
59
100

4
0
4
88
96

4
0
4
92
100

4
0
19
110
133

3.0
0.0
14.3
82.7
100.0

8.9
0.9
10.8
79.4
100.0

4
1
4
78
87

5
1
5
90
100

32
4
38
328
402

8.0
1.0
9.5
81.6
100.1

%

2003 RVNA titer (IU/ml)
$0.25
0.12–,0.25
0.05–,0.12
,0.05
Total

0
0
15
22
37

2004 RVNA titer (IU/ml)
$0.25
0.12–,0.25
0.05–,0.12
,0.05
Total

28
3
34
250
315

lected at OWC during 2004 were positive
for RVNA ($0.05 IU/ml), but all titers
were ,0.12 IU/ml. We observed the
highest percentage of positive samples in
May (38%, n58), followed by June (17%,
n56) and July (13%, n58). We collected

no positive sera from OWC during April
(n56), August (n55), or September (n53).
We collected 17 pairs and three triads
of matched (two to three samples from the
same individual) sera from 17 individual
raccoons in 2003 and 2004 (Table 6). Over

FIGURE 4. Proportion of live-trapped raccoons that were rabies virus-neutralizing antibody–positive, by
titer and month, before and after distribution of oral rabies vaccines on Plum Brook Station, Erie County,
Ohio, USA, May–October 2003 and March–October 2004.
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TABLE 4. Cross tabulations of prevalence of rabies virus-neutralizing antibody (RVNA) and tetracycline in
sera and teeth collected live-trapped raccoons after distribution of oral rabies vaccine-bait units on Plum
Brook Station, Erie County, Ohio, USA, September 2003 to October 2003 and September 2004 to
October 2004.
RVNA
2003
Positive

Tetracycline
Positive
Negative
Total

2004

Negative

Total

Positive

Negative

Total

n

%

n

%

n

%

n

%

n

%

n

%

2
6
8

25
75
100

9
79
88

10
90
100

11
85
96

12
89
100

3
6
9

33
68
100

17
61
78

22
78
100

20
67
87

23
77
100

the 2 yr, eight pairs of matched sera were
obtained within the prebait period, seven
pairs were obtained before and after
baiting, two pairs were obtained within
the post-bait period, and three pairs were
obtained during the post-bait period in
2003 and the prebait period in 2004.
Titers of RVNA did not change in only
one matched pair that was collected
during the postbait period. Otherwise,
RVNA titers increased in seven of 20
(35%) matched pairs and decreased in 12
of 20 (60%) matched pairs. Three of seven
matched pairs with increasing RVNA
titers were collected before and after
baiting. Each of these three raccoons had
no detectable titers before baiting but
were RVNA-positive after baiting in 2004.
Three raccoons had antibody titers that
increased between the post-bait period in
2003 and the prebait period in 2004. Only
one of these three individuals had detect-

able RVNA titer in the initial sample.
Seven of twelve matched sera with RVNA
titers that declined were collected within
the prebait period. Titer levels of RVNA
declined in four of twelve matched sera
that were collected during the pre- and
postbait periods. One of 12 matched pairs
where RVNA titers declined was collected
within the postbait period.
Median tissue culture infectious dose of
vaccine (TCID50)

The geometric mean titer (GMT) of VRG virus in the VBUs after 51 days of
refrigeration was 9.0 log10 TCID50/ml
(8.2–9.2 log10 TCID50/ml). The GMT for
shaded VBUs was 7.2 log10 TCID50/ml
(,5.2–9.2 log10 TCID50/ml). No virus was
detected after 51 days in any of the VBUs
exposed to sunlight. Mean daily temperature during the VBU exposure experiment
was 16 C with a mean daily maximum of

TABLE 5. Cross-tabulations of the prevalence of rabies virus-neutralizing antibody (RVNA) and vaccinia
virus vector antibody (VVA) in sera collected from live-trapped raccoons before and after distribution of oral
rabies vaccines on Plum Brook Station, Erie County, Ohio, USA, April 2003 to October 2003.
RVNA
Prevaccine
Positive

VVA
Positive
Negative
Total

Post-vaccine

Negative

Total

Positive

Negative

Total

n

%

n

%

n

%

n

%

n

%

n

%

4
11
15

27
73
100

5
17
22

237
77
100

9
28
37

24
76
100

3
5
8

37
63
100

16
77
93

17
83
100

19
82
101

19
81
100
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TABLE 6. Change in RVNA titers (IU/ml) of matched sera collected from individual raccoons live-trapped on
Plum Brook Station, Erie County, Ohio, USA, May 2003 to October 2003 and March 2004 to October 2004.

Prevaccine

Pre- to
post-vaccinea

Post-vaccine

Post- to
prevaccineb

Total

Period

n

%

n

%

n

%

n

%

n

%

Change
Increase
None
Decrease
Total

1
0
7
8

12
0
88
100

3
0
4
7

43
0
57
100

0
1
1
2

0
50
50
100

3
0
0
3

100
0
0
100

7
1
12
20

35
5
60
100

a

Within a single year.

b

Between 2003 and 2004.

22 C and mean daily minimum of 11 C
(ranging from 33 C on 25 August 2003 to
0 C on 6 October 2003).
DISCUSSION
Target population density

Doubling (to account for juveniles) the
Mth estimate of adult population size and
dividing by area used by radio-marked
raccoons, we estimated that density of our
target population averaged 91 raccoons/km2
in 2003 and 2004. With a realized baiting
density of 70 VBU/km2 both years, 0.6–0.9
baits were distributed per raccoon in 2003
and 2004. Raccoon densities vary from 6–
11/km2 in rural areas to 40–125/km2 in
urban areas (Table 7). The predominantly
native vegetation of Plum Brook, bounded
on one side by residential development and
three sides by cropland, resembles the
suburban–rural interface of the midwestern
United States. Den sites in buildings,
absence of hunting, and close proximity to
anthropogenic food sources are features
that typically support high-density raccoon
populations (Prange et al., 2003, 2004).
Target population response to VBU distribution

Presence of bait biomarker within
specific annuli of teeth collected during
September–October indicated that 17–
27% (mean523%) of raccoons ingested
baits after VBU distribution in 2003 and
2004. However, biomarker was present in
73% of teeth collected during April 2004

to August 2004, with 58% prevalence in
the 2003 annulus. Bait biomarker was not
detected before baits were first distributed
in 2003, yet tetracycline was detected in
the 2002 annulus of 1–8% of teeth
collected thereafter. Furthermore, tetracycline was detected in the 2004 annulus
in 11% of teeth collected before the
second baiting. Blackwell et al. (2004)
found that 83% of VBUs were removed by
raccoons and nontarget species within
1 wk of hand-placement (at 75 VBU/
km2) on five of our trapping grids in
2002, so it is unlikely that any baits
remained for consumption by raccoons
after winter 2003. Pooling all teeth collected after baiting in 2003 and before
baiting in 2004 and disregarding the
putative year of biomarker deposition,
58% of our target population ingested
baits after VBUs were distributed in 2003;
54% ingested baits after VBUs were
distributed a second time in 2004. Tetracycline is not always detected in calcific
tissue after raccoons ingest ORV baits
(Johnston et al., 2005) so we may have
underestimated bait contact.
Although background titers of RVNA
and VVA were present in our population
before baiting, bait distribution affected
prevalence of RVNA in the target population. Prevalence of RVNA was associated
with bait ingestion in 2003 and 2004
because tetracycline-positive raccoons
were 2.6 and 1.7 times more likely to be
RVNA-positive than were tetracycline-
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TABLE 7. Published estimates of raccoon population densities in eastern North American by landscape type
and method of estimation.
Population density (No./km2)

Landscape type

Estimation method

Literature source

125
100
94
40
91
68
37
33
11

Urban
Urban
Urban
Urban
Suburban/rural
Suburban
Suburban
Suburban/rural
Rural

Mark–recapture
Mark–recapture
Mark–recapture
Mark–recapture
Mark–recapture
Mark–recapture
Mark–recapture
Line transect
Mark–recapture

Riley et al., 1998
Rosatte, 2000
Schinner and Cauley, 1974
Gehrt, 2002
This study
Hoffmann and Gottschang, 1977
Gehrt, 2002
Blackwell et al., 2004
Gehrt, 2002

negative raccoons after baiting each year.
The diminished strength of association
between biomarker and RVNA prevalence
in 2004 would be expected if some
raccoons that were tetracycline- and
RVNA-positive in 2003 did not ingest
baits in 2004. Raccoons that were VVApositive also were 2.6 times more likely to
be RVNA-positive than VVA-negative
raccoons after baiting in 2003, indicating
that V-RG vaccine contained in baits
stimulated production of RVNA in some
individuals.
Prevalence of RVNA titers .0.25 IU/ml
increased after baiting in 2003, providing
additional evidence that VBU distribution
influenced RVNA titers in our target
population. We found no raccoons with
RVNA titers .0.12 IU/ml before VBUs
were first distributed in 2003, but titers
$0.25 were detected before (9%) and
after (4%) bait distribution in 2004. With
elevated RVNA titers present before
baiting in 2003 and 2004, we expected to
observe a strong anamnestic response if a
large fraction of our population had
previously been exposed to rabies virus
or consumed the V-RG vaccine, but this
was not the case. However, we did observe
modest increases in the proportions of
RVNA-positive raccoons with titers
$25 IU/ml after baiting in 2003 and
2004, and an overall increase in prevalence of titers $25 IU/ml 7–15 mo after
initial baiting in 2003.
Averaging years, 9.8% of our target

population had elevated (.0.05 IU/ml)
RVNA titers after baiting. This was not
substantially higher than 8–9% prevalence
of RVNA-positive ($0.05 IU/ml) raccoons
observed in two ORV-naı̈ve areas near the
Ohio ORV zone in 2005 (WS, 2005). In
contrast, RVNA prevalence ($0.05 IU/ml)
was 33% after ,65 VBU/km2 were first
distributed in the northeastern Ohio ORV
zone where rabies was epizootic (ODH,
2002). Prevalence of RVNA was nearly
doubled when ODH (2001) increased bait
densities from 75 VBU/km2 (22% antibody
prevalence) to 300 VBU/km2 (41% antibody prevalence). ODH (2001) distributed baits and sampled raccoons over a
larger area that included a wider range of
habitats than Plum Brook. Because the
eastern Ohio ORV zone is predominantly
rural, ODH (2001) probably distributed
baits to a target population with lower
overall density than we estimated on Plum
Brook (Table 7).
The low prevalence of RVNA that we
observed after baiting can be attributed in
part to distributing ,1 VBU per raccoon.
However, with at least 56% of our target
population consuming baits and 9.8%
prevalence of RVNA in sera after VBU
distribution each year, only 17% of
raccoons developed elevated RVNA titers
after ingesting baits. The vaccine contained in VBUs exposed to ambient
conditions remained viable for several
weeks after distribution, so defective
vaccine cannot explain the low prevalence
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of RVNA after baiting in 2003. Blackwell
et al. (2004) found that nearly 90% of
vaccine sachets recovered from baits that
disappeared 1 wk after hand-placement
on five of our trapping grids in 2002 were
perforated, suggesting oral contact with
vaccine. Applying our estimate of bait
ingestion rate to the estimate of oral
contact rate made by Blackwell et al.
(2004), half (50.6%) of our population may
have ingested vaccine without acquiring
sufficient quantities of vaccine to elicit
serologic response.
A high prevalence of RVNA (41%) was
observed before baits were distributed on
a naı̈ve site. With positive RVNA titers
($0.05 IU/ml) detected before VBUs
were distributed in 2003, we cannot
definitively separate background RVNA
titers from those produced by ingesting
infective doses of vaccine after baiting.
Surprisingly, RVNA titers declined between pre- and post-bait sampling periods
in 2003 and 2004, suggesting an independent seasonal cycle of elevated RVNA in
our population. The same trend also was
evident on a nearby control site in 2004. A
seasonal decline in prevalence of positive
antibody titers (,0.05 IU/ml) to the vaccinia virus in the same sera tested for
RVNA also was observed. If all background RVNA titers disappeared from our
population before baiting, then prevalence
of RVNA as a result of baiting was
correctly expressed as the proportions of
sera with elevated RVNA titers (.0.05 IU/
ml) during post-bait sampling periods
(8.4–11.3%). However, if we disregard
antibody titers that were considered background (0.05–0.12 IU/ml) during the prebait period in 2003, only 4.2–5.7% of our
target population developed elevated
RVNA titers after baiting in 2003 and
2004.
Jenkins et al. (1988) also found RVNA
titers of $0.05 IU/ml to ,0.25 IU/ml in
raccoon populations naı̈ve to rabies epizootics. Jenkins et al. (1988) attributed titers
,0.25 IU/ml to nonspecific antibodies
and considered such levels to be insuffi-

cient to produce immune protection to
rabies challenge (see LaFon, 2002). The
CDC reports titers .0.05 IU/ml as positive (Rupprecht et al., 1988) and animals
with titers .0.05 IU/ml have been found
to be protected from fatal rabies virus
infections following challenge in laboratory experiments (Rupprecht et al., 1988).
Although populations of RVNA-positive
wild raccoons have been regularly monitored after distribution of VBUs since
inception of the ORV program, there is
disagreement about the minimum antibody titer that prevents fatal rabies
infections in free-ranging populations.
Regardless of what minimum antibody
titer confers immunoprotection, ,12%
of our target population could have been
protected from rabies infection after
baiting in 2003 and 2004.
A vaccination rate of 63% was sufficient
to stop the spread of rabies on the Cape
Cod peninsula (Robbins et al., 1998)
where natural land features and a narrow
ORV zone may have facilitated success.
This rate is well above the prevalence of
RVNA observed before or after baiting in
our study. Although the level of population immunity necessary to provide a
barrier to rabies outbreaks remains controversial (Rupprecht et al., 1995; World
Health Organization, 2005), rates .80%
have been suggested in some modeling
studies (Coyne et al., 1989; Bruggemann,
1992). Regardless, the westward spread of
raccoon rabies seems to have been
achieved in Ohio with considerably lower
prevalence of elevated RVNA titers after
baiting.
Sources of background RVNA

Possible explanations for the presence
of background RVNA include previous
vaccination, translocation of infected raccoons, and exposure to a nonraccoon
variant of the rabies virus or other viral
infections that induce production of nonspecific antibodies. High prebait prevalence of RVNA might be expected after a
large-scale trap–vaccinate–release pro-
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gram (Broadfoot et al., 2001). However,
no local veterinarians or rehabilitators that
were contacted had knowledge that vaccinated raccoons were released in the area.
Furthermore, RVNA-positive raccoons
were widely distributed across the study
area, an unlikely occurrence if vaccinated
animals had been released, especially on a
highly secure area such as Plum Brook.
Although translocation of raccoons infected with rabies is known to occur
(Dobson, 2000), we discount this explanation because all raccoons that we captured
appeared healthy; moribund raccoons
were not reported on Plum Brook during
our study. Translocation of an infected
raccoon into a naı̈ve area with high
raccoon density would likely have caused
a local outbreak of rabies that would have
been detected by Plum Brook personnel
or local residents.
Detection of RVNA after a raccoonrabies epizootic is not uncommon (Carey
and McClean, 1983). Prevalence of RVNA
in a raccoon-rabies endemic area has been
reported to be 10–28% (Bigler et al., 1973;
Jenkins et al., 1988), considerably less than
we observed before baiting in 2003. The
detection of RVNA-positive animals also
has been reported for skunks (Mephitis
mephitis) by Rosatte and Gunson (1984;
21%) and raccoons (Hill et al., 1992; 5%)
that were sampled outside of enzootic
areas. Further, nonfatal exposure to rabies
has been documented in spotted hyenas
(Crocuta crocuta) in the Serengeti and in
an oncilla (Leopardus tigrinus) in Bolivia
(East et al., 2001; Deem et al., 2004).
Nonfatal infection of individuals exposed to a nonraccoon variant of rabies
virus is another explanation for presence
of RVNA in a wild raccoon population
outside of an enzootic area. Bat (Chiroptera) and skunk variants of rabies virus
have been identified in Ohio (ODH,
2006a). We found strong evidence of a
seasonal cycle of RVNA prevalence in our
population. Prevalence of RVNA was high
during May–June and diminished by
August in both years of our study. A
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similar trend also was found at our control
site. These results support the possibility
of exposure to a nonraccoon variant of
rabies virus during winter or early spring.
Hill et al. (1993) demonstrated that
raccoons can develop RVNA titers after
exposure to the skunk strain of rabies
virus. The relatively low number of skunks
captured (only three over ,4,000 trapnights) during both years of our study
suggests that RVNA-positive raccoons
were not likely exposed to a skunk variant
of rabies virus in our study. Also, no cases
of skunk rabies have been documented in
Erie County, Ohio, since 1989, whereas
bat strain rabies cases are sporadic but
geographically widespread in Ohio (ODH,
2007).
Rabies infection can occur from exposure to air in caves with rabid bats as well
as from ingestion of rabies-infected tissues
(Constantine, 1967; East et al., 2001).
Raccoons used abandoned structures on
Plum Brook that also provide suitable
roosting sites for bats. Although little is
known regarding bat populations on Plum
Brook, we suggest that use of man-made
structures by both raccoons and bats on
the area could provide venues for transmission of the rabies virus. Although we
recognize that exposure of raccoons to the
bat variants of rabies virus may not
completely account for the high RVNA
prevalence in the 2003 predistribution
sample, exposure to a nonraccoon variant
of rabies virus is a plausible explanation
for the presence of RVNA in areas where
rabies is not enzootic.
Although we distributed less than one
VBU per raccoon to a high-density target
population, over half of the raccoons
ingested baits. Nevertheless, ,12% of
raccoons developed RVNA titers that
could be considered immunoprotective
to rabies infection. Distributing more baits
to high-density raccoon populations in
semiurban areas would not only expose
bait to more individuals, but also provide
more opportunities for individuals that
encounter baits to consume an infective
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dose of vaccine. Consequently, accurate
estimates of target population density are
needed to assure that adequate densities
of VBUs are distributed to successfully
deliver a cost-effective ORV program.
There is a need to estimate target
population densities in areas close to
dense human populations where targeted
VBU distribution may be an alternative
method of distribution. The MNKA method severely underestimated raccoon density in our population. Density estimates
increased with a removal model (CPUE),
but were still well below those obtained
with more robust methods based on
capture histories. Finally, if naturally
occurring background RVNA titers occur
in naı̈ve populations, then estimates of
prevalence of RVNA obtained during
operational baiting programs might incorrectly attribute those titers to ORV
distribution, especially in spring or early
summer. Development of nonspecific
RVNAs without exposure to vaccine may
explain why RVNAs are found in raccoons
that are tetracycline-negative in bone or
tooth sections (Johnston et al., 2005).
Serologic surveys should be conducted if
possible before distributing oral vaccine
baits to thoroughly evaluate efficacy of an
ORV program. Finally, the source and
seasonal changes in expression of RVNA
in naı̈ve area requires further investigation, as does the level of immunoprotection afforded by low antibody titers against
infection with rabies virus.
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